Basel, Switzerland

Zorica Dragic

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Zorica Dragic: Innovator in Polyomavirus Research

Introduction

Zorica Dragic is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of virology, particularly in the development of treatments for polyomavirus infections. With a total of nine patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents is a groundbreaking invention related to polyomavirus neutralizing antibodies. This invention focuses on anti-VP1 antibodies, antibody fragments, and their applications for the prevention and treatment of polyomavirus infection and associated diseases. The implications of this research are vast, potentially leading to new therapeutic options for patients affected by these viral infections.

Career Highlights

Zorica Dragic is currently employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to innovative research and development projects. Her dedication to advancing medical science is evident through her numerous patents and ongoing research efforts.

Collaborations

Zorica has worked alongside notable colleagues, including Johanna Abend and Adam Lloyd Feire. These collaborations have further enriched her research and have played a crucial role in the development of her patented inventions.

Conclusion

Zorica Dragic's contributions to the field of polyomavirus research highlight her innovative spirit and commitment to improving healthcare. Her work continues to pave the way for advancements in the treatment of viral infections, showcasing the importance of research and collaboration in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…